Collectively, the pathway enrichments in the LAM1 population consisted mostly of extracellular signaling-, metabolism-, and senescence-related terms, and in the LAM2 population, of pathway terms that intersect with cardiovascular disease, inflammation, and cancer, suggesting response to environmental cues for LAM1s and pro-disease signaling for LAM2s. Here, SELL is linked to cancer.